Exacerbation of inflammatory bowel disease associated with use of celecoxib.

Suppr

超能文献

作者信息

Bonner G F

出版信息

Am J Gastroenterol. 2001 Apr;96(4):1306-8. doi: 10.1111/j.1572-0241.2001.03730.x.

DOI:10.1111/j.1572-0241.2001.03730.x

PMID:11316199

Abstract

摘要

相似文献

Exacerbation of inflammatory bowel disease associated with use of celecoxib.

Am J Gastroenterol. 2001 Apr;96(4):1306-8. doi: 10.1111/j.1572-0241.2001.03730.x.

[Lower gastrointestinal hemorrhage associated with celecoxib].

An Med Interna. 2003 Sep;20(9):497.

Selective use of selective nonsteroidal anti-inflammatory drugs in inflammatory bowel disease.

Clin Gastroenterol Hepatol. 2006 Feb;4(2):157-9. doi: 10.1016/j.cgh.2005.11.007.

[Hyperkalemia and celecoxib].

Med Clin (Barc). 2002 Jun 8;119(1):36-7.

Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy.

Aliment Pharmacol Ther. 2007 May 15;25(10):1211-22. doi: 10.1111/j.1365-2036.2007.03312.x.

[Nephrotic syndrome associated to celecoxib].

Nefrologia. 2005;25(1):81-2.

Celecoxib (Celebrex): 1 year later.

CMAJ. 2000 Apr 4;162(7):1044-6, 1048-50.

Celecoxib-induced photoallergic drug eruption.

Int J Dermatol. 2004 Jun;43(6):459-61. doi: 10.1111/j.1365-4632.2004.02149.x.

Allergic vasculitis associated with celecoxib.

Rheumatology (Oxford). 2002 Dec;41(12):1453-5.

Aseptic meningitis possibly associated with celecoxib.

Ann Pharmacother. 2004 Jan;38(1):172. doi: 10.1345/aph.1D238.

引用本文的文献

Medical treatment of pouchitis: a guide for the clinician.

Therap Adv Gastroenterol. 2021 Jun 27;14:17562848211023376. doi: 10.1177/17562848211023376. eCollection 2021.

Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study.

Intest Res. 2019 Oct;17(4):496-503. doi: 10.5217/ir.2019.00050. Epub 2019 Oct 14.

Potential Strategies in the Prevention of Nonsteroidal Anti-inflammatory Drugs-Associated Adverse Effects in the Lower Gastrointestinal Tract.

Gut Liver. 2020 Mar 15;14(2):179-189. doi: 10.5009/gnl19201.

Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of Cyclooxygenase-2 by Rofecoxib in the Rat.

Cells. 2019 Mar 15;8(3):251. doi: 10.3390/cells8030251.

Niacin ameliorates ulcerative colitis via prostaglandin D-mediated D prostanoid receptor 1 activation.

EMBO Mol Med. 2017 May;9(5):571-588. doi: 10.15252/emmm.201606987.

Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease.

Pharmaceuticals (Basel). 2010 Apr 12;3(4):1084-1092. doi: 10.3390/ph3041084.

Ulcerative colitis with inflammatory polyposis in a teenage boy: a case report.

World J Gastroenterol. 2015 Jan 21;21(3):1044-8. doi: 10.3748/wjg.v21.i3.1044.

The role of PGE2 in intestinal inflammation and tumorigenesis.

Prostaglandins Other Lipid Mediat. 2015 Jan-Mar;116-117:26-36. doi: 10.1016/j.prostaglandins.2014.10.002. Epub 2014 Oct 22.

Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.

Cochrane Database Syst Rev. 2014 Oct 23;2014(10):CD007744. doi: 10.1002/14651858.CD007744.pub2.

Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use.

Gastroenterol Hepatol (N Y). 2013 Dec;9(12):803-10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验